Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Amit Verma, Shanisha Gordon-Mitchell et al.|Journal of Clinical Investigation|2024Cited by 20
Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling InhibitionSarah Aminov, Amit Verma, Orsi Giricz et al.|Blood|2022Cited by 3
Abstract 4820: Anti-CD72 nanobody-based CAR-T affinity maturation leads to improved in vitro efficacy versus low antigen density lymphoma models, but limited benefit in vivoAdila Izgutdina, Arun P. Wiita, Tasfia Rashid et al.|Cancer Research|2025Cited by 1
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Arun P. Wiita, Tasfia Rashid et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndromeMadeline Niederkorn, John D. Crispino, Lavanya Bezavada et al.|Journal of Clinical Investigation|2026Cited by 1